Pfizer withdrew its pill for sickle cell disease amid heightened European scrutiny, triggered by death rates seen in clinical ...

Liposomal Doxorubicin Market Liposomal Doxorubicin Market Dublin, Sept. 30, 2024 (GLOBE NEWSWIRE) -- The "Liposomal ...

Swissmedic is expected to decide on the approval of the first new drug for Alzheimer’s disease in two decades. The decision ...

Convincing healthcare providers and patients of Neffy’s reliability during allergic reactions will require extensive ...

Revenues of Indian pharmaceutical companies are projected to grow by 9-11% in the current financial year, a moderation from ...

SIFI, a leading international ophthalmic company, announced that is has received a Notice of Allowance from the European Patent Office ...

Psilocybin, a psychedelic compound, offers promising relief for depression, improving symptoms and social functioning beyond ...

Kezar Life Sciences, Inc. , a clinical-stage biotechnology company developing a novel small molecule to treat unmet needs in immune-mediated diseases, today announced the voluntary cessation in ...

This projected revenue, as per the rating agency, will be driven by 9-11 per cent growth from the US market, 7-9 per cent each from the European and domestic markets, and 11-13 per cent from the ...

Ahram's Pharmaceutical Conference, which began Saturday under the patronage of Prime Minister Mostafa Madbouly, discussed the ...

Australia is one of the biggest markets for child exploitation material from the Philippines, with experts pushing for the ...

What does it feel like to go for 30 hours on end without food? For 17-year-old Krishnaaram Muthukumaran, it “wasn’t too bad” ...